XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) AND MEZZANINE EQUITY (Unaudited) - USD ($)
Total
Preferred Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Common Stock
Balance, shares at Dec. 31, 2020     415,328       13,485,128
Balance, amount at Dec. 31, 2020 $ (4,161,013) $ 0 $ (611,854) $ 14,333,285 $ (18,750,824) $ 854,896 $ 13,484
Foreign currency translation adjustment, net (473,578) 0 $ 0 0 0 (473,578) 0
Sale of treasury stock to third party, shares     65,000        
Sale of treasury stock to third party, amount 250,000 0 $ 650 249,350 0 0 $ 0
Restricted stock issued to a consultant, shares             1,800,000
Restricted stock issued to a consultant, amount 1,189,450 0   1,187,650     $ 1,800
Conversion of notes payable into shares of common stock, shares             781,819
Conversion of notes payable into shares of common stock, amount 2,564,364 0 0 2,563,582 0 0 $ 782
Net loss (2,173,903) 0 $ 0 0 (2,173,903) 0 $ 0
Balance, shares at Mar. 31, 2021     350,328       16,066,947
Balance, amount at Mar. 31, 2021 (2,804,680) 0 $ (611,204) 18,333,867 (20,924,727) 381,318 $ 16,066
Balance, shares at Dec. 31, 2020     415,328       13,485,128
Balance, amount at Dec. 31, 2020 (4,161,013) 0 $ (611,854) 14,333,285 (18,750,824) 854,896 $ 13,484
Net loss (6,489,502)            
Stock-based compensation 5,147,076            
Balance, shares at Sep. 30, 2021     293,208       17,332,628
Balance, amount at Sep. 30, 2021 4,650,961 0 $ (439,844) 30,146,413 (25,240,326) 167,386 $ 17,332
Balance, shares at Mar. 31, 2021     350,328       16,066,947
Balance, amount at Mar. 31, 2021 (2,804,680) 0 $ (611,204) 18,333,867 (20,924,727) 381,318 $ 16,066
Foreign currency translation adjustment, net 284 0 0 0 0 284 0
Restricted stock issued to a consultant, amount 1,968,000 0 0 1,968,000 0 0 0
Net loss (2,379,056) 0 0 0 (2,379,056) 0 $ 0
Conversion of related party debt, shares             500,000
Conversion of related party debt, amount 3,000,000 0 0 2,999,500 0 0 $ 500
Forgiveness of related party debt 600,000 0 $ 0 0 0 0 $ 0
Balance, shares at Jun. 30, 2021     350,328       16,566,947
Balance, amount at Jun. 30, 2021 384,548 0 $ (611,204) 23,901,367 (23,303,783) 381,602 $ 16,566
Foreign currency translation adjustment, net (214,216) 0 0 0 0 (214,216) 0
Restricted stock issued to a consultant, amount 1,989,626 0 0 1,989,626 0 0 $ 0
Conversion of notes payable into shares of common stock, shares             321,300
Conversion of notes payable into shares of common stock, amount 1,314,117 0 0 1,313,796 0 0 $ 321
Net loss (1,936,543) 0 0 0 (1,936,543) 0 $ 0
Conversion of related party debt, shares             375,000
Conversion of related party debt, amount 2,250,000 0 $ 0 2,249,625 0 0 $ 375
Cancellation of treasury shares, shares     57,120       (57,120)
Cancellation of treasury shares, amount 0 0 $ 171,360 (171,303) 0 0 $ (57)
Conversions of convertible note payable, shares             126,501
Conversions of convertible note payable, amount 569,429 0 0 569,302 0 0 $ 127
Beneficial conversion feature discount related to convertible notes payable 294,000 0 $ 0 294,000 0 0 $ 0
Balance, shares at Sep. 30, 2021     293,208       17,332,628
Balance, amount at Sep. 30, 2021 4,650,961 0 $ (439,844) $ 30,146,413 (25,240,326) 167,386 $ 17,332
Balance, shares at Dec. 31, 2021       387,424     17,544,509
Balance, amount at Dec. 31, 2021 4,379,463 0 39,675,753 $ (816,707) (34,345,506) (151,621) $ 17,544
Foreign currency translation adjustment, net (405,229) 0 0 0 0 (405,229) $ 0
Conversion of notes payable into shares of common stock, shares             238,000
Conversion of notes payable into shares of common stock, amount 973,420 0 0 973,182 0 0 $ 238
Net loss 203,347 0 0 0 203,347 0 0
Adjustments for prior periods from adopting ASU 2020-06 (240,752) $ 0 0 (294,000) 53,248 0  
Issuance of Series A preferred stock, net of issuance costs of $547,700, shares   6,000          
Issuance of Series A preferred stock, net of issuance costs of $547,700, amount 0 $ 5,452,300 0   0 0 $ 0
Cashless exercise of warrants, shares             829,471
Cashless exercise of warrants, amount 0 $ 0 0 $ (829) 0 0 $ 829
Balance, shares at Mar. 31, 2022   6,000   (387,424)     18,611,980
Balance, amount at Mar. 31, 2022 4,910,249 $ 5,452,300 (816,707) $ 40,354,106 (34,088,911) (556,850) $ 18,611
Balance, shares at Dec. 31, 2021       387,424     17,544,509
Balance, amount at Dec. 31, 2021 4,379,463 $ 0 39,675,753 $ (816,707) (34,345,506) (151,621) $ 17,544
Net loss (3,010,684)            
Stock-based compensation 27,221            
Balance, shares at Sep. 30, 2022   1,500   (387,424)     26,365,404
Balance, amount at Sep. 30, 2022 3,443,833 $ 1,712,035 (816,707) $ 61,194,291 (54,345,250) (2,614,866) $ 26,365
Balance, shares at Mar. 31, 2022   6,000   (387,424)     18,611,980
Balance, amount at Mar. 31, 2022 4,910,249 $ 5,452,300 (816,707) $ 40,354,106 (34,088,911) (556,850) $ 18,611
Foreign currency translation adjustment, net (1,028,875) 0 0 0 0 (1,028,875) 0
Restricted stock issued to a consultant, amount 0 0 0 0 0 0 0
Net loss (1,241,256) 0 0 0 (1,241,256) 0 0
Forgiveness of related party debt 0 0 0 0 0 0 $ 0
Cashless exercise of warrants, shares             455,316
Cashless exercise of warrants, amount 0 $ 0 0 (455) 0 0 $ 455
Conversion of Series A preferred stock, shares   (3,034)         4,892,222
Conversion of Series A preferred stock, amount 2,427,693 $ (2,427,693) 2,422,801       $ 4,892
Conversion of convertible debt, shares             39,339
Conversion of convertible debt, amount 38,144 0 0 38,105 0 0 $ 39
Deemed dividend upon downround of preferred stock and warrants 0 0 0 16,669,894 (16,669,894) 0 0
Deemed dividend on preferred stock 0 0 0 352,807 (352,807) 0 0
Stock-based compensation 24,101 $ 0 0 $ 24,101 0 0 $ 0
Balance, shares at Jun. 30, 2022   2,966   (387,424)     23,998,857
Balance, amount at Jun. 30, 2022 5,130,056 $ 3,024,607 59,861,359 $ 59,861,359 (52,352,868) (1,585,725) $ 23,997
Foreign currency translation adjustment, net (1,029,141) 0 0 0 0 (1,029,141) 0
Net loss (1,972,775) $ 0 0 0 (1,972,775) 0 $ 0
Conversion of Series A preferred stock, shares   (1,466)         2,359,047
Conversion of Series A preferred stock, amount 1,332,180 $ (1,332,179) 1,329,820 1,329,820 0 0 $ 2,360
Deemed dividend on preferred stock (19,607) 19,607 0 0 (19,607) 0 0
Stock-based compensation 3,120 $ 0 3,112 $ 3,112 0 0 $ 8
Stock-based compensation, shares             7,500
Balance, shares at Sep. 30, 2022   1,500   (387,424)     26,365,404
Balance, amount at Sep. 30, 2022 $ 3,443,833 $ 1,712,035 $ (816,707) $ 61,194,291 $ (54,345,250) $ (2,614,866) $ 26,365